CBD Oil and Parkinson’s Disease

NewsGuard 100/100 Score

Cannabis is the most widely used recreational drug worldwide, with many variants that have been used both medicinally in the treatment or management of various diseases, including chronic pain, as well as being used recreationally to achieve a high.

Recently, Canada became the first major western country after Uruguay to legalize marijuana/cannabis for recreational and medicinal use and cultivation. The United Kingdom has now made an exception for medicinal cannabis in the treatment of severe epilepsy, chemotherapy-related illness and multiple sclerosis, while still retaining a Class B illegal status for recreational usage (possession and distribution).

Cannabis plant. Imge Credit: Lifestyle Discover / Shutterstock
Lifestyle Discover / Shutterstock

What is CBD oil?

Medical cannabis is often sold as cannabidiol (CBD) oil. It is a major cannabinoid from hemp plants. However, CBD oil does not usually contain tetrahydrocannabinol (THC) which is the main psychoactive substance of cannabis. Dried cannabis can also be sold in some countries/states as medical marijuana, and often produces the full effects of cannabis.

Can CBD oil treat Parkinson’s?

Parkinson’s disease clinically manifests as dyskinesia (impairment of movement), resting tremor, bradykinesia (slow movements), dystonia (stiffness of muscles including facial muscles), a stooped posture, drooling, sexual and urinary dysfunction, and in some cases psychiatric symptoms including psychosis, dementia and depression.

The brain has a rich expression of cannabinoid receptors in various sites, such as the G-protein coupled receptor GPR6 within the basal ganglia (a key part of the brain affected by Parkinson’s). Studies investigating the oral intake of CBD oil (and smoking cannabis) in the treatment of Parkinsonian symptoms have observed generally positive results.

One observational study reported rapid alleviation of Parkinsonian symptoms (including bradykinesia and tremor) upon cannabis smoke inhalation (CBD + THC) in around 79% of patients (out of 28). In another study, 56% of a small cohort of patients showed improvement in mood and sleep issues.

In a larger study of 339 Czech patients with Parkinson’s who were routinely using cannabis leaves orally (CBD + THC), there was significant improvement in resting tremors, bradykinesia and rigidity with little or no side effects overall. Symptoms were ameliorated particularly in patients who had been using cannabis for over 3 or more months.

Studies focusing on the use of CBD oil alone show mixed results. One study showed that oral CBD oil reduced psychotic symptoms in Parkinson’s patients, but with little effect on dyskinesia. However, it produced generic improvement in physical state as well as in insomnia-related issues. Larger studies are necessary to confirm these findings, however, as these studies had a relatively small sample size (<20).

Medical Marijuana and Parkinson's Part 3 of 3


Cannabis has many proven beneficial effects on health, especially in neurology and psychiatry. More research is desperately needed to convince governments to legalize medicinal cannabis for treatment purposes, following Canada’s example)

Nnumerous observational studies have reported improvement in symptoms with the use of CBD oil by patients with Parkinson’s, Alzheimer’s and MS patients. However, some studies have questioned the efficacy of CBD oil alone, or if THC, linalool and limonene extracts should also be incorporated in the specific treatment of these conditions, such as for neuroprotection.

Unlike THC, CBD oil alone does not show the psychoactive properties of cannabis. For this reason THC must be administered in a careful and controlled way. Unfortunately, as long as cannabis remains a controlled drug under most international laws, research is hampered and the stigma associated with it remains. It is an encouraging sign in the UK that the use of medicinal CBD oil is now allowed for the most severe cases, but the law needs to move to full decriminalization to allow the use of THC oil as well, and to encourage more investment in medical research on the effects of cannabis on health.

Further Reading

Last Updated: Jun 17, 2023

Dr. Osman Shabir

Written by

Dr. Osman Shabir

Osman is a Postdoctoral Research Associate at the University of Sheffield studying the impact of cardiovascular disease (atherosclerosis) on neurovascular function in vascular dementia and Alzheimer's disease using pre-clinical models and neuroimaging techniques. He is based in the Department of Infection, Immunity & Cardiovascular Disease in the Faculty of Medicine at Sheffield.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Shabir, Osman. (2023, June 17). CBD Oil and Parkinson’s Disease. News-Medical. Retrieved on April 25, 2024 from https://www.news-medical.net/health/CBD-Oil-and-Parkinsons-Disease.aspx.

  • MLA

    Shabir, Osman. "CBD Oil and Parkinson’s Disease". News-Medical. 25 April 2024. <https://www.news-medical.net/health/CBD-Oil-and-Parkinsons-Disease.aspx>.

  • Chicago

    Shabir, Osman. "CBD Oil and Parkinson’s Disease". News-Medical. https://www.news-medical.net/health/CBD-Oil-and-Parkinsons-Disease.aspx. (accessed April 25, 2024).

  • Harvard

    Shabir, Osman. 2023. CBD Oil and Parkinson’s Disease. News-Medical, viewed 25 April 2024, https://www.news-medical.net/health/CBD-Oil-and-Parkinsons-Disease.aspx.


  1. Ivy Levine Ivy Levine Philippines says:

    Have you ever felt sick to your stomach after taking CBD oil?

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study deciphers how misfolded protein drives dopaminergic neuron loss in Parkinson's